Fred vom Saal and his team found that the Food and Drug Administration-approved “safe” daily exposure amount of BPA may be enough to have implications for the development of Type 2 diabetes and other metabolic diseases.
Fred vom Saal and his team found that the Food and Drug Administration-approved “safe” daily exposure amount of BPA may be enough to have implications for the development of Type 2 diabetes and other metabolic diseases.